ATE205217T1 - Steroide als mittel zur kontrazeption und gegen osteoporose - Google Patents

Steroide als mittel zur kontrazeption und gegen osteoporose

Info

Publication number
ATE205217T1
ATE205217T1 AT98200518T AT98200518T ATE205217T1 AT E205217 T1 ATE205217 T1 AT E205217T1 AT 98200518 T AT98200518 T AT 98200518T AT 98200518 T AT98200518 T AT 98200518T AT E205217 T1 ATE205217 T1 AT E205217T1
Authority
AT
Austria
Prior art keywords
contraception
steroids
against osteoporosis
osteoporosis
Prior art date
Application number
AT98200518T
Other languages
English (en)
Inventor
H J J Loozen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE205217T1 publication Critical patent/ATE205217T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98200518T 1997-02-21 1998-02-18 Steroide als mittel zur kontrazeption und gegen osteoporose ATE205217T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97102884 1997-02-21

Publications (1)

Publication Number Publication Date
ATE205217T1 true ATE205217T1 (de) 2001-09-15

Family

ID=8226513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98200518T ATE205217T1 (de) 1997-02-21 1998-02-18 Steroide als mittel zur kontrazeption und gegen osteoporose

Country Status (26)

Country Link
US (2) US6077873A (de)
EP (1) EP0869132B1 (de)
JP (1) JP4392066B2 (de)
KR (1) KR19980071540A (de)
CN (2) CN100522984C (de)
AR (1) AR011680A1 (de)
AT (1) ATE205217T1 (de)
AU (1) AU723713B2 (de)
BR (1) BR9800718B1 (de)
CA (1) CA2229960C (de)
CZ (1) CZ50598A3 (de)
DE (1) DE69801539T2 (de)
DK (1) DK0869132T3 (de)
ES (1) ES2164400T3 (de)
HU (1) HU223755B1 (de)
ID (1) ID19947A (de)
IL (1) IL123195A (de)
NO (1) NO310724B1 (de)
NZ (1) NZ329789A (de)
PL (1) PL188079B1 (de)
PT (1) PT869132E (de)
RU (1) RU2182153C2 (de)
SG (1) SG60203A1 (de)
TR (1) TR199800282A1 (de)
TW (1) TW403736B (de)
ZA (1) ZA981344B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123195A (en) * 1997-02-21 2002-11-10 Akzo Nobel Nv Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
EP1212345B1 (de) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Oral wirksame 7-alpha-alkyl androgene
CO5271709A1 (es) 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
TWI225068B (en) * 2000-06-06 2004-12-11 Akzo Nobel Nv Anellated steroid compounds having contraceptive and anti-osteoporosis activity
JP2002241395A (ja) * 2001-02-16 2002-08-28 Taiho Yakuhin Kogyo Kk エストラ−４，６−ジエン−３，１７−ジオンの製造方法
US7250289B2 (en) 2002-11-20 2007-07-31 Affymetrix, Inc. Methods of genetic analysis of mouse
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
WO2008075930A1 (es) * 2006-12-20 2008-06-26 Landsteiner Scientific, S.A. De C.V. Composiciones de risedronato y vitamina d3
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare
WO2023000135A1 (en) * 2021-07-19 2023-01-26 Context Biopharma Inc. Processes of making onapristone and intermediates thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0411736B1 (de) * 1989-08-04 1994-05-04 Schering Aktiengesellschaft 11 Beta-substituierte 16 alpha, 17alpha-Methylen-estra-4,9-dien-3-one
ATE172469T1 (de) * 1989-08-04 1998-11-15 Schering Ag 11 beta-aryl-gona-4,9-dien-3-one
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
IL123195A (en) * 1997-02-21 2002-11-10 Akzo Nobel Nv Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
US6077873A (en) 2000-06-20
NO980737D0 (no) 1998-02-20
MX9801428A (es) 1998-12-31
AR011680A1 (es) 2000-08-30
EP0869132B1 (de) 2001-09-05
AU723713B2 (en) 2000-09-07
AU5541298A (en) 1998-08-27
BR9800718B1 (pt) 2009-08-11
PL188079B1 (pl) 2004-12-31
HUP9800373A2 (hu) 1998-11-30
NO980737L (no) 1998-08-24
DE69801539T2 (de) 2002-04-18
BR9800718A (pt) 1999-06-29
EP0869132A1 (de) 1998-10-07
JPH10273499A (ja) 1998-10-13
IL123195A (en) 2002-11-10
PT869132E (pt) 2002-01-30
NZ329789A (en) 1999-09-29
DE69801539D1 (de) 2001-10-11
RU2182153C2 (ru) 2002-05-10
ID19947A (id) 1998-08-27
HK1016188A1 (en) 1999-10-29
NO310724B1 (no) 2001-08-20
ZA981344B (en) 1998-08-27
KR19980071540A (ko) 1998-10-26
CA2229960A1 (en) 1998-08-21
JP4392066B2 (ja) 2009-12-24
US6313180B1 (en) 2001-11-06
HU223755B1 (hu) 2005-01-28
ES2164400T3 (es) 2002-02-16
CN101092442A (zh) 2007-12-26
HU9800373D0 (en) 1998-04-28
DK0869132T3 (da) 2002-01-07
PL324939A1 (en) 1998-08-31
CN100522984C (zh) 2009-08-05
CZ50598A3 (cs) 1998-09-16
IL123195A0 (en) 1998-09-24
CA2229960C (en) 2007-12-18
HUP9800373A3 (en) 1999-06-28
TW403736B (en) 2000-09-01
SG60203A1 (en) 1999-02-22
TR199800282A1 (xx) 1998-09-21
CN1197076A (zh) 1998-10-28

Similar Documents

Publication Publication Date Title
DE69839893D1 (de) Anti-östrogene Steroide, pharmazeutische Zusammensetzungen und Verwendungen davon
DE69903453D1 (de) Ungesättigte oxim-derivate und ihre anwendung als latente säuren
ATE264960T1 (de) Paneelanordnung und verbindungsmittel
DE69933042D1 (de) Hochauflösender und hochluminesender plasmabildschirm und ansteurungsverfahren dafür
DE69932575D1 (de) Sprachkodierer und sprachdekodierer
ATE277593T1 (de) Emulgiersystem und emulsionen
DE60043864D1 (de) Wechselrichtersteuerverfahren und korrespondierendes Wechselrichtersteuergerät
DE69918871D1 (de) Zementzusatzmittel und Zementzusammensetzung
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
DE50014254D1 (de) Verankerung und Fahrzeug
ATA36297A (de) Alkylphenylbisacylphosphinoxide und photoinitiatormischungen
DE69820278D1 (de) Mischverfahren und mischvorrichtung
DE69909616D1 (de) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indol und estrogen als kombinationpräparate
DE59903869D1 (de) Verwendung von nanoskaligen sterolen und sterolestern
DE60140383D1 (de) Zementdispergiermittel und dieses enthaltende Zementzusammensetzung
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69831750D1 (de) Biozide und biozide tücher
DE60008799D1 (de) Stromversorgungshilfsaggregat und dessen betriebsverfahren
DE50002478D1 (de) Neue kombination von loteprednol und antihistaminika
DE60027440D1 (de) Impfstoff gegen hbv und hpv
ZA200402458B (en) Estrogen/gestagen combination preparation and application thereof
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
DE60039547D1 (de) Bestückungsverfahren und Bestückungsvorrichtung
ATE205217T1 (de) Steroide als mittel zur kontrazeption und gegen osteoporose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee